FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Syracuse football and basketball teams face challenges as they navigate injuries and roster overhauls, while North Carolina's football team struggles with red-zone issues.
Berkshire Hathaway reports strong Q3 results, but Buffett to step down as CEO, raising questions about the company's future capital allocation decisions.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Syracuse football and basketball teams face challenges as they navigate injuries and roster overhauls, while North Carolina's football team struggles with red-zone issues.
Berkshire Hathaway reports strong Q3 results, but Buffett to step down as CEO, raising questions about the company's future capital allocation decisions.
